Compared with prescription of pioglitazone, prescription of rosiglitazone was associated with an increased risk of stroke, heart failure, and all-cause mortality and an increased risk of the composite of AMI, stroke, heart failure, or all-cause mortality in patients 65 years or older.
No takes yet. Share an insight, caveat, or question.
Graham et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: